Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Asthma × Azithromycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

COVID-19 2 Skin Neoplasms 1 Respiratory Sounds 1 Respiratory Distress Syndrome 1 Pneumonia, Viral 1 Pharmacokinetics 1 Neoplasms 1 Lymphoma, Follicular 1 Hematologic Neoplasms 1 Cytokine Release Syndrome 1 Asthma 1 Adenomatous Polyposis Coli 1

Interventions

Fluticasone-Salmeterol Drug Combination 3 Etanercept 3 Fluticasone 2 Budesonide 2 Beclomethasone 2 perflutren 1 laninamivir 1 fluticasone-formoterol 1 Sulfur Hexafluoride 1 Prednisolone 1 NVP-QAV680 1 Lysine Acetyltransferase 5 1 Health Information Exchange 1 Formoterol Fumarate 1 Escitalopram 1 CS 8958 1 Budesonide, Formoterol Fumarate Drug Combination 1 Bronchial Thermoplasty 1 Blood Specimen Collection 1 Azithromycin 1 Amoxicillin-Potassium Clavulanate Combination 1 Albuterol 1 Adrenal Cortex Hormones 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02517099 2023-03-06

PrIGMa

Imperial College London

Phase 2 Completed

60 enrolled 10 charts

Asthma, Lymphoma, Follicular, Respiratory Sounds

Data powered by HemOnc (CC BY 4.0) Colophon ⚡